References
- Bergman B. Psychosocial issues in the treatment of patients with lung cancer. Lung Cancer 1992;8:1–20
- Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003;123: 97–104S
- Naughton MJ, Herndon JE, Shumaker SA, et al. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res 2002;11:235–48
- Gralla RJ. Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life. Oncologist 2004;9(Suppl 6):14–24
- Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 1993;29A(Suppl 1):S51–8
- Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 1994;73:2087–98
- Cella DF, Bonomi AE, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995;12:199–220
- Aaronson NK, Ahmedzai A, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76
- Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994;30A:635–42
- Ihde DC, Pass HI, Glatstein E. Small cell lung cancer. Chapter 30 Cancer of the Lung. In Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 5th edn. Philadelphia: Lippincott-Raven, 1997:911
- Yoo H, Suh C, Kim S, et al. Korean translation and validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) version 4. Qual Life Res 2006;15:161–6
- von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999;17:658–67
- Devita VT, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology, 3rd edn. Philadelphia: Lippincott, 1989
- Guttman L. Some necessary conditions for common factor analysis. Psychometrika 1954;19:149–61
- Kaiser HE. The application of electronic computers to factor analysis. Educ Psychol Meas 1960;20:141–51
- Kaiser HE. A note on Guttman’s lower bound for the number of common factors. Br J Stat Psychol 1961;14:1
- Kline P. A handbook of psychological testing. London: Routledge, 1993
- Ware JE, Jr., Harris WJ, Gandek B, et al. MAP-R for Windows: Multitrait/Multi-Item Scale Analysis Software. Boston, MA: Health Assessment Lab, 1997
- Nunnally JC. Psychometric Theory, 2nd edn. New York: McGraw-Hill, 1978
- Shrout PE, Fleiss JL. Intraclass correlation: use in assessing rater reliability. Psychol Bull 1979; 86:420–8
- Lin, LI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255–68
- Cohen, Jacob. Statistical Power Analysis for the Behavioral Sciences, Revised edn. New York: Academic Press, 1977
- Svensson E. Comparison of the quality of assessments using continuous and discrete ordinal rating scales. Biom J 2000;42:417–34
- Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chron Dis 1987;40:1129–33
- Hollen PJ, Gralla RJ, Kris MG, et al. A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life? Qual Life Res 2005;14:837–47
- Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Draft guidance. Washington, DC: Food and Drug Administration/Center for Drug Evaluation and Research/Center for Biologics Evaluation and Research/Center for Devices and Radiological Health, February 2006. Available at: http://www.fda.gov/cder/Guidance/5460dft.pdf [Last accessed 26 August 2007]